OmniTier Inc.’s new bioinformatics platform, CompStorTM Novos, takes a de novo assembly-based variant calling approach to the challenge of whole genome sequencing. We caught up with Jon Coker, Omnitier’s CTO, to discuss how this approach matches up to rival techniques, and how high-performance computing approaches like Omnitier’s hope to bring personalized medicine a step closer and boost biology in coming years.Read More
In areas, such as food analysis where detection of contaminants may be imperative to prevent dangers to consumers, speed and reliability is key. We spoke to Tim Jenkins from Waters Corporation, about their coupling of DART to the QDa mass detector with a software solution aimed to enhance compound identification.Read More
High content screeening (HCS) has become a staple tool for scientists trying to find out how molecules alter our cells' biological systems. The huge volume of data that HCS produces is both its strength and weakness. As assays become more complex, companies like Genedata are turning to AI-based approaches to help streamline HCS analysis. I spoke to Genedata's Head of Science, Dr. Stephan Steigele, to find out more.Read More
A recent assessment of the success of the drug development process put the percentage of phase I programs that make it to approval at 13.8%. That figure points to a crisis of attrition within the industry. Netramark, a Toronto-based start-up claim they have a machine learning-powered solution to that crisisRead More
Loud background noise doesn’t just annoy people by getting in the way of good conversation – it also affects voice activated devices. AudioTelligence, a start-up based out of Cambridge, say they have developed the world’s first digital solution to this ‘cocktail party problem’.
Whilst all life sciences have benefited immensely from digitization and automation in the last ten years, tools designed specifically for biologists have been somewhat scarce. London-based Synthace are aiming to change that. In this blog, we ask Synthace co-founder Chris Grant how his company's platform Antha was developed and why it has earned Synthace a “Cool Vendor of the Year” award from Gartner.Read More
Next-generation sequencing has revolutionized science by significantly increasing the speed and volume of data that can be generated for a given genome. As NGS technologies have become more affordable, in-house sequencing has become more popular, shifting away from outsourced projects using service providers. In this blog, Thermo Fisher Scientific’s Karen Velardi explains how labs and users can utilize data management techniques to get the most from their NGS results.
Cell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.Read More
Electronic Lab Notebooks (ELNs) are often advertised as the next step in laboratory technology, but uptake has remained stubbornly low despite a wide range of solutions being available on the market. Here, we ask ELN provider labfolder's Co-Founder and CEO Simon Bungers what the industry can do to improve uptake, and how ELNs can answer the question of how to improve data integrity in modern research.Read More
SMi Presents the 2nd Annual Conference: Injectable Drug Delivery 2019
May 15 - May 16, 2019